Polaris Venture Management Co. V as of June 30, 2018
Portfolio Holdings for Polaris Venture Management Co. V
Polaris Venture Management Co. V holds 12 positions in its portfolio as reported in the June 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Cardlytics (CDLX) | 31.3 | $57M | 2.6M | 21.76 | |
| Fate Therapeutics (FATE) | 15.3 | $28M | 2.5M | 11.34 | |
| Kala Pharmaceuticals | 13.9 | $26M | 1.9M | 13.73 | |
| Neuronetics (STIM) | 12.0 | $22M | 825k | 26.61 | |
| Selecta Biosciences | 11.6 | $21M | 1.6M | 13.25 | |
| T2 Biosystems | 7.8 | $14M | 1.8M | 7.74 | |
| Arsanis | 3.7 | $6.8M | 1.9M | 3.63 | |
| Trevena | 1.6 | $3.0M | 2.1M | 1.44 | |
| Genocea Biosciences | 0.9 | $1.7M | 2.0M | 0.86 | |
| Atyr Pharma Inc Common Stock Usd 0.001 | 0.9 | $1.7M | 1.8M | 0.91 | |
| Pulmatrix | 0.9 | $1.6M | 3.6M | 0.45 | |
| Dare Bioscience | 0.2 | $382k | 326k | 1.17 |
